Literature DB >> 26858290

Introduction to the Analysis of Survival Data in the Presence of Competing Risks.

Peter C Austin1, Douglas S Lee2, Jason P Fine2.   

Abstract

Competing risks occur frequently in the analysis of survival data. A competing risk is an event whose occurrence precludes the occurrence of the primary event of interest. In a study examining time to death attributable to cardiovascular causes, death attributable to noncardiovascular causes is a competing risk. When estimating the crude incidence of outcomes, analysts should use the cumulative incidence function, rather than the complement of the Kaplan-Meier survival function. The use of the Kaplan-Meier survival function results in estimates of incidence that are biased upward, regardless of whether the competing events are independent of one another. When fitting regression models in the presence of competing risks, researchers can choose from 2 different families of models: modeling the effect of covariates on the cause-specific hazard of the outcome or modeling the effect of covariates on the cumulative incidence function. The former allows one to estimate the effect of the covariates on the rate of occurrence of the outcome in those subjects who are currently event free. The latter allows one to estimate the effect of covariates on the absolute risk of the outcome over time. The former family of models may be better suited for addressing etiologic questions, whereas the latter model may be better suited for estimating a patient's clinical prognosis. We illustrate the application of these methods by examining cause-specific mortality in patients hospitalized with heart failure. Statistical software code in both R and SAS is provided.
© 2016 The Authors.

Entities:  

Keywords:  cumulative incidence function; data interpretation, statistical; incidence; models, statistical; proportional hazards models; risk assessment; survival analysis

Mesh:

Year:  2016        PMID: 26858290      PMCID: PMC4741409          DOI: 10.1161/CIRCULATIONAHA.115.017719

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  13 in total

Review 1.  Evaluating health outcomes in the presence of competing risks: a review of statistical methods and clinical applications.

Authors:  Ravi Varadhan; Carlos O Weiss; Jodi B Segal; Albert W Wu; Daniel Scharfstein; Cynthia Boyd
Journal:  Med Care       Date:  2010-06       Impact factor: 2.983

Review 2.  Survival methods.

Authors:  Sowmya R Rao; David A Schoenfeld
Journal:  Circulation       Date:  2007-01-02       Impact factor: 29.690

3.  Tutorial in biostatistics: competing risks and multi-state models.

Authors:  H Putter; M Fiocco; R B Geskus
Journal:  Stat Med       Date:  2007-05-20       Impact factor: 2.373

4.  Prognostic models with competing risks: methods and application to coronary risk prediction.

Authors:  Marcel Wolbers; Michael T Koller; Jacqueline C M Witteman; Ewout W Steyerberg
Journal:  Epidemiology       Date:  2009-07       Impact factor: 4.822

5.  Competing risk of death: an important consideration in studies of older adults.

Authors:  Sarah D Berry; Long Ngo; Elizabeth J Samelson; Douglas P Kiel
Journal:  J Am Geriatr Soc       Date:  2010-03-22       Impact factor: 5.562

Review 6.  A competing risks analysis should report results on all cause-specific hazards and cumulative incidence functions.

Authors:  Aurelien Latouche; Arthur Allignol; Jan Beyersmann; Myriam Labopin; Jason P Fine
Journal:  J Clin Epidemiol       Date:  2013-02-14       Impact factor: 6.437

7.  Competing risk regression models for epidemiologic data.

Authors:  Bryan Lau; Stephen R Cole; Stephen J Gange
Journal:  Am J Epidemiol       Date:  2009-06-03       Impact factor: 4.897

8.  Effectiveness of public report cards for improving the quality of cardiac care: the EFFECT study: a randomized trial.

Authors:  Jack V Tu; Linda R Donovan; Douglas S Lee; Julie T Wang; Peter C Austin; David A Alter; Dennis T Ko
Journal:  JAMA       Date:  2009-11-18       Impact factor: 56.272

9.  Competing risks and the clinical community: irrelevance or ignorance?

Authors:  Michael T Koller; Heike Raatz; Ewout W Steyerberg; Marcel Wolbers
Journal:  Stat Med       Date:  2011-09-23       Impact factor: 2.373

10.  Competing risks analyses: objectives and approaches.

Authors:  Marcel Wolbers; Michael T Koller; Vianda S Stel; Beat Schaer; Kitty J Jager; Karen Leffondré; Georg Heinze
Journal:  Eur Heart J       Date:  2014-04-07       Impact factor: 29.983

View more
  488 in total

1.  Association of estimated sleep duration and naps with mortality and cardiovascular events: a study of 116 632 people from 21 countries.

Authors:  Chuangshi Wang; Shrikant I Bangdiwala; Sumathy Rangarajan; Scott A Lear; Khalid F AlHabib; Viswanathan Mohan; Koon Teo; Paul Poirier; Lap Ah Tse; Zhiguang Liu; Annika Rosengren; Rajesh Kumar; Patricio Lopez-Jaramillo; Khalid Yusoff; Nahed Monsef; Vijayakumar Krishnapillai; Noorhassim Ismail; Pamela Seron; Antonio L Dans; Lanthé Kruger; Karen Yeates; Lloyd Leach; Rita Yusuf; Andres Orlandini; Maria Wolyniec; Ahmad Bahonar; Indu Mohan; Rasha Khatib; Ahmet Temizhan; Wei Li; Salim Yusuf
Journal:  Eur Heart J       Date:  2019-05-21       Impact factor: 29.983

2.  Health factors and spinal cord injury: a prospective study of risk of cause-specific mortality.

Authors:  Yue Cao; Nicole DiPiro; James S Krause
Journal:  Spinal Cord       Date:  2019-02-25       Impact factor: 2.772

3.  Platelet Counts and Postoperative Stroke After Coronary Artery Bypass Grafting Surgery.

Authors:  Jörn A Karhausen; Alan M Smeltz; Igor Akushevich; Mary Cooter; Mihai V Podgoreanu; Mark Stafford-Smith; Susan M Martinelli; Manuel L Fontes; Miklos D Kertai
Journal:  Anesth Analg       Date:  2017-10       Impact factor: 5.108

4.  External validity of two nomograms for predicting distant brain failure after radiosurgery for brain metastases in a bi-institutional independent patient cohort.

Authors:  Roshan S Prabhu; Robert H Press; Danielle M Boselli; Katherine R Miller; Scott P Lankford; Robert J McCammon; Benjamin J Moeller; John H Heinzerling; Carolina E Fasola; Kirtesh R Patel; Anthony L Asher; Ashley L Sumrall; Walter J Curran; Hui-Kuo G Shu; Stuart H Burri
Journal:  J Neurooncol       Date:  2017-12-07       Impact factor: 4.130

Review 5.  Top ten errors of statistical analysis in observational studies for cancer research.

Authors:  A Carmona-Bayonas; P Jimenez-Fonseca; A Fernández-Somoano; F Álvarez-Manceñido; E Castañón; A Custodio; F A de la Peña; R M Payo; L P Valiente
Journal:  Clin Transl Oncol       Date:  2017-12-07       Impact factor: 3.405

6.  Contralateral prophylactic mastectomy in young women with breast cancer: a population-based analysis of predictive factors and clinical impact.

Authors:  A Bouchard-Fortier; N N Baxter; R Sutradhar; K Fernandes; X Camacho; P Graham; M L Quan
Journal:  Curr Oncol       Date:  2018-12-01       Impact factor: 3.677

7.  Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial.

Authors:  Carolyn S Calfee; Kevin L Delucchi; Pratik Sinha; Michael A Matthay; Jonathan Hackett; Manu Shankar-Hari; Cliona McDowell; John G Laffey; Cecilia M O'Kane; Daniel F McAuley
Journal:  Lancet Respir Med       Date:  2018-08-02       Impact factor: 30.700

8.  Leisure-Time Physical Activity and Cardiovascular Mortality in an Elderly Population in Northern Manhattan: A Prospective Cohort Study.

Authors:  Ying Kuen Cheung; Yeseon P Moon; Erin R Kulick; Ralph L Sacco; Mitchell S V Elkind; Joshua Z Willey
Journal:  J Gen Intern Med       Date:  2016-10-17       Impact factor: 5.128

9.  Team-based versus traditional primary care models and short-term outcomes after hospital discharge.

Authors:  Bruno D Riverin; Patricia Li; Ashley I Naimi; Erin Strumpf
Journal:  CMAJ       Date:  2017-04-24       Impact factor: 8.262

10.  Lung function, respiratory symptoms and venous thromboembolism risk: the Atherosclerosis Risk in Communities Study.

Authors:  Y Kubota; S J London; M Cushman; A M Chamberlain; W D Rosamond; S R Heckbert; N Zakai; A R Folsom
Journal:  J Thromb Haemost       Date:  2016-11-08       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.